Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released May 13, 2024, after the close
10-Q filed May 13, 2024, 43 days after period end · 0000950170-24-058644
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $250.00K | $0.00 | — |
| Net Income | -$3.53M | -$2.34M | -$4.21M | -$4.03M |
| EPS Diluted | -$4.59 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$8.13 |
| -$12.96 |
| -$0.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
